Proven immune markers even now maintain their relevance for clinical decision-generating in breast cancer therapy with even extended meanings. Estrogen receptor (ER) level mustn't only be categorized in positive or destructive. Very low ER ranges ≤ten% of labeled cells has to be taken care of in a different way https://hilarya097cnx8.wiki-promo.com/user